New drug trial aims to tame rare, dangerous low blood sugar disorder
Disease control
Ongoing
This study is testing if an investigational drug called RZ358 can help people with congenital hyperinsulinism, a rare genetic disorder that causes dangerously low blood sugar. About 56 participants, from infants to adults, will receive RZ358 or a placebo along with their standard…
Phase: PHASE3 • Sponsor: Rezolute • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC